Schrodinger, Inc.

SDGR Nasdaq SEC CIK 1490978
Follow Schrodinger Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $64.5M +18.7% vs same quarter last year
Net income −$37.7M −15% vs same quarter last year
EPS, diluted −$0.50 −11.1% vs same quarter last year
Operating cash flow −$47.6M +23.1% vs same quarter last year
Revenue by quarter
$88.3M
$59.6M
$54.8M
$54.3M
$87.2M
$58.6M
$58.9M
$64.5M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$200M$0$200M$400MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$255.9M−$103.3M
FY24$207.5M−$187.1M
FY23$216.7M$40.7M
FY22$181M−$149.2M
FY21$137.9M−$101.2M
FY20$108.1M−$24.5M
FY19$85.5M−$24.6M
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−150%−100%−50%0%50%100%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2555.7%−65.2%−40.4%
FY2463.6%−100.8%−90.2%
FY2364.9%−81.9%18.8%
FY2255.8%−81.1%−82.4%
FY2147.6%−80.8%−73.4%
FY2058.7%−56.4%−22.6%
FY1957.4%−45.3%−28.7%
FY18---
Free cash flowOperating cash flow minus capital expenditure
−$200M−$150M−$100M−$50M$0$50MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$12.5M
FY24−$164.7M
FY23−$150.1M
FY22−$127.7M
FY21−$77.8M
FY20$14.2M
FY19−$27.9M
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Schrodinger
  • Healthcare median
−100%−50%0%50%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearSchrodingerHealthcare median
FY25−40.4%−30.6%
FY24−90.2%−47%
FY2318.8%−58%
FY22−82.4%−80.4%
FY21−73.4%−71.8%
FY20−22.6%−62.2%
FY19−28.7%−46.2%
FY18-−49.6%